Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Gilead Sciences (NASDAQ: GILD) Executive Transactions Leave 19,785 Shares Held

GILEAD SCIENCES, INC. (NASDAQ: GILD) Chief Medical Officer Berger Dietmar’s option exercise left him with 19,785 shares on Sep. 10, 2026. The transaction represented about 2.7% of his resulting shareholding. A separate transaction on the same date reduced his reported holding to 19,522 shares. …

Vinay Lochav | 14 September 2026

Hempfusion Wellness (OTC:CBDHF) Goes Quiet: Why It Could Still Be One to Watch

Few tickers illustrate the fate of the pandemic-era cannabidiol boom as starkly as Hempfusion Wellness Inc. (OTC:CBDHF). Once a well-distributed U.S. CBD and wellnessBrandwith shelves in thousands of retail stores, the company now trades at a fraction of a cent on the over-the-counter market, …

Nitish Kishor | 14 September 2026

Gilead (NASDAQ: GILD) CEO Transactions Leave 581,683 Shares, 83,300 Derivatives

GILEAD SCIENCES, INC. (NASDAQ: GILD) CEO Daniel Patrick O’Day exercised options for 8,780 shares on 10 September 2026, leaving him with 585,913 shares after the transaction. The filing also records a forfeiture of shares and an exercise involving derivative securities.

Vinay Lochav | 14 September 2026

Gilead Sciences (NASDAQ: GILD) CFO Reports Option Exercise and 1,347-Share Forfeiture

GILEAD SCIENCES, INC. (NASDAQ: GILD) CFO Andrew D. Dickinson exercised options for 2,797 shares on September 10, 2026. The transaction left Dickinson with 168,443 shares, while a separate entry recorded the forfeiture of 1,347 shares at $144.81 per share.

Vinay Lochav | 14 September 2026

Conexeu Sciences (NASDAQ:CNXU) Stock Gains Ground: Key Levels and Catalysts to Watch

Conexeu Sciences Inc has quietly become one of the more distinctive biotechnology newcomers on theNasdaqthis year, a preclinical regenerative-medicine story that only reached public markets in 2026. Trading under the ticker CNXU, shares closed up 4.94% at $4.46 at last closing, putting technical levels …

Nitish Kishor | 14 September 2026

Health Catalyst (NASDAQ: HCAT), Inc. CEO Forfeits 35,244 Shares at $1.67

Health Catalyst, Inc. (NASDAQ: HCAT) CEO Albert Benjamin forfeited 35,244 shares at $1.67 per share on Sep. 10, 2026. The transaction represented about 2.5% of his prior share holding.

Vinay Lochav | 14 September 2026

Hemab Therapeutics (NASDAQ:COAG) Goes Quiet: Why It Could Still Be One to Watch

A quietTrading sessioncan mask a busy year. Hemab Therapeutics Holdings, whose shares closed down 1.20% at $39.40 at last closing, spent the spring and summer of 2026 building a clinical dossier around rare and serious bleeding disorders while its stock more than doubled from …

Nitish Kishor | 14 September 2026

What's Next for Bellrock Brands (OTC:DXBRF)? The Stock Waits for Its Next Big Signal

There is penny-stock territory, and then there is what Bellrock Brands (OTC:DXBRF) has become. The cannabis products company changes hands at a fraction of a cent, a price that leaves its entire public equity valued at little more than pocket change. No independently verifiable …

Nitish Kishor | 14 September 2026

Eikon Therapeutics (NASDAQ:EIKN) Adds a New Chief Scientific Officer: Is It Gearing Up for Its Next Clinical Chapter?

Eikon Therapeutics, Inc. has long been one of biotechnology's better-known platform stories, and its move ontoNasdaqunder the ticker EIKN has given public investors a way to follow it. Shares closed down 2.93% at $8.94 at last closing even as the company signals a step …

Nitish Kishor | 14 September 2026

Energy Resource Abundance (OTC:ERAO) Breaks Higher: What Investors Should Watch

Few tickers illustrate the mechanics of the sub-penny market quite like Energy Resource Abundance, Inc. (OTC:ERAO). Trading at a fraction of a cent, shares closed up 44% at last closing, an eye-catching figure that sounds dramatic, yet at these price levels a move of …

Nitish Kishor | 14 September 2026
Support

Hi! How can we help you today?

Loading…